Mumbai: Scientists from premier institutions such as Indian Institute of Technology-Bombay, Bhabha Atomic Research Centre, Indian Council for Medical Research and Haffkine institute and National Institute of Immuno Haematology would showcase their research in Homoeopathy at a two-day World Summit to be held here from April 11.
Researches by India's premier institutes presented at a press conference here yesterday show that Homoeopathy has given rise to a new hope to patients suffering from dreaded HIV, tuberculosis and the deadly blood disease Hemophilia.
In a pioneering two-year long study, city-based homoeopath Dr Rajesh Shah has developed a new medicine for AIDS patients, sourced from human immunodeficiency virus (HIV) itself.
The drug has been tested on humans for safety and efficacy and the results are encouraging, said Dr Shah. Larger studies with and without concomitant conventional ART (Antiretroviral therapy) can throw more light in future on the scope of this new medicine, he said.
Dr Shah's scientific paper for debate has just been published in Indian Journal of Research in Homoeopathy (IJRH), the Official publication of the Central Council for Research in Homoeopathy (CCRH) in its online edition. CCRH is a Union Government-run institute.
The drug resulted in improvement of blood count (CD4 cells) of HIV patients, which is a very positive and hopeful sign, he said and expressed the hope that this will encourage an advanced research into the subject.
Sourcing of medicines from various virus and bacteria has been a practise in the homoeopathy stream long before the prevailing vaccines came into existence, said Dr Shah, who is also organising secretary of Global Homoeopathy Foundation (GHF), an NGO, and holds a Limca Book record for treating patients from 180 countries.
Dr Shah, who has been campaigning for the integration of homoeopathy and allopathic treatments, said this combination has proven to be useful for several challenging diseases. He teamed up with noted virologist Dr Abhay Chowdhury and his team at the premier Haffkine Institute and developed a drug sourced from TB germs of MDR-TB patients.
The research by Dr Kanjaksha Ghosh of Indian Council of Medical Research (ICMR), National Institute of Immuno Haematology (NIIH) and Dr Tapas Kundu, showed that homoeopathy demonstrated positive results in patients of Hemophilia - a deadly blood disease that leads to uncontrolled bleeding that cannot be managed with regular medicines.
Usage of allopathy-homoeopathy combination, however, showed that hemophilia patients did get relief. The medicines were tested on 494 patients whose profuse bleeding was effectively checked.
Dr Jayesh Bellare, HOD- Chemical Engineering-IIT-Bombay, worked on an altogether different subject of homoeopathy. His research has shown that homoeopathic medicines have nano-particles, breaks the myth that homoeopathic medicines don't have any content.
Former BARC scientist Dr G D Jindal developed an electrical device which was used by him and Dr Akalpita Paranjape, a physicist, and ex-scientist BARC, capable of demonstrating the effects of homoeopathic medicines in a matter of few minutes. This is bound to silence the critics of homoeopathy who fail to see science behind the time-tested system of medicine, Dr Shah added.
Some of the eminent scientists from Austria, Brazil, Italy, Holland, UK, USA, etc. Have also done path-breaking research. They are coming to India to showcase their fundamental research in homoeopathy.
"If extensive and strategic research is carried out in future, homoeopathy is likely to have complete transformation, which in turn, could bring a paradigm shift in health care," Dr Shah said.
